Battery Ventures takes majority stake in water-safety firm Phigenics
What's the deal? PhigenicsDealroom has a profile for this one. Try Dealroom →, an Illinois-based water-management company, has taken a majority-growth investment from Battery Ventures, a global technology-focused firm. The deal, announced September 17, 2026, puts Battery general partner Zack Smotherman and principal Max Kaye on the company's board.
What's the endgame? Founded in 2004, Phigenics helps healthcare facilities and others cut the risk of Legionella and other waterborne pathogen outbreaks. It runs accredited labs to test water samples and sells phiAnalytics, software that helps customers monitor water-management programs and report results to regulators.
Why now? The company serves more than 250 organisations, including major hospital systems, VA facilities, and ambulatory surgery centres, all facing tighter water-safety standards. It is also pushing into new sectors such as hospitality and retail.
Where the money goes: The investment is meant to fund new and existing products and expansion into new markets. Battery will work with CEO Mark Crockett, who has led Phigenics since August 2024, and the existing management team.
The signal: Battery brings notable sector credibility, having backed water-related technology businesses for more than two decades, including firms in analytical testing, instrumentation, and sensor technologies. "Because Phigenics covers the full water-safety lifecycle, it stays constantly engaged with its customers and has become an increasingly critical partner as compliance demands, particularly in healthcare, keep growing," Smotherman said.
Read more: business.theantlersamerican.com
Image credit: Phigenics
